Stock Review: Tracking Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Marco Green
March 6, 2018

Philadelphia Financial Management Of San Francisco Llc sold 29,185 shares as the company's stock rose 13.94% with the market. The biopharmaceutical company reported ($0.62) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.60) by ($0.02). The company has market cap of $1.97 billion. 482,989 shares of the company traded hands, compared to its average volume of 304,760. It has outperformed by 40.63% the S&P500.

The Habit Restaurants, Inc., a holding company, operates fast casual restaurants under The Habit Burger Grill name. Perceptive Advisors Llc bought 905,000 shares as the company's stock declined 4.63% while stock markets rallied. The hedge fund run by Daniel Gold held 373,481 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $13.94 million, down from 480,437 at the end of the previous reported quarter. Acceleron Pharma has a 12-month low of $24.37 and a 12-month high of $46.93. The stock increased 1.85% or $0.55 during the last trading session, reaching $30.35. About 199,129 shares traded.

Acceleron Pharma (NASDAQ:XLRN) last announced its quarterly earnings results on Tuesday, February 27th. It has underperformed by 39.13% the S&P500.The move comes after 5 months positive chart setup for the $1.97B company.

Among 6 analysts covering Century Communities (NYSE:CCS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 60% are positive. Century Communities had 16 analyst reports since August 12, 2015 according to SRatingsIntel. The firm earned "Market Outperform" rating on Thursday, August 25 by JMP Securities. Stephens maintained the stock with "Overweight" rating in Wednesday, October 11 report. The firm has "Market Perform" rating given on Tuesday, June 13 by Oppenheimer. The rating was maintained by FBR Capital on Thursday, February 23 with "Outperform". The company was reinitiated on Tuesday, August 8 by Citigroup. (NASDAQ:XLRN) rating on Wednesday, September 20. Morgan Stanley initiated the stock with "Overweight" rating in Thursday, August 13 report. (NASDAQ:XLRN) on Thursday, December 17 with "Neutral" rating. Using ratings provided by analysts polled by Zacks Research, we note that the current average broker rating on shares of Consolidated Communications Holdings, Inc. (NASDAQ:AXTI). Bridgeway Capital Mgmt reported 0.03% of its portfolio in AXT, Inc. Ser Automobile Association accumulated 0.01% or 91,480 shares.

Since September 12, 2017, it had 1 buying transaction, and 12 insider sales for $19.61 million activity. Quantbot Technologies LP raised its stake in shares of Acceleron Pharma by 416.3% in the 3rd quarter. (NASDAQ:XLRN) was sold by Quisel John D. On Wednesday, January 3 the insider Sherman Matthew L sold $197,868. The stock of Acceleron Pharma Inc. (NASDAQ:XLRN) for 14,620 shares. Nationwide Fund Advsrs holds 0.05% of its portfolio in Acxiom Corporation (NASDAQ:ACXM) for 467,832 shares. $27.59 million worth of Acceleron Pharma Inc. More interesting news about The Habit Restaurants, Inc. George Jean sold $3.76 million worth of stock.

Investors sentiment decreased to 1.21 in Q3 2017. The stock decreased 1.39% or $0.17 during the last trading session, reaching $12.04.

A number of other hedge funds and other institutional investors have also made changes to their positions in XLRN. MetLife Investment Advisors LLC bought a new position in Acceleron Pharma in the 4th quarter valued at $739,000. Gsa Cap Partners Ltd Liability Partnership holds 0.02% in Newfield Exploration Company (NYSE:NFX) or 10,091 shares. Principal Group Incorporated Inc reported 0% of its portfolio in Acceleron Pharma Inc. Royal Bank & Trust Of Canada has invested 0% in Acceleron Pharma Inc. (NASDAQ:XLRN) for 963,000 shares. Leerink Swann analyst G. Porges forecasts that the biopharmaceutical company will post earnings of ($0.62) per share for the quarter. Finally, Bailard Inc. acquired a new position in shares of Acceleron Pharma during the fourth quarter worth $340,000. It also upped Ptc Therapeutics Inc (Call) (NASDAQ:PTCT) stake by 200,000 shares and now owns 460,000 shares. The Australia-based Platinum Inv Mgmt has invested 0.06% in Acceleron Pharma Inc. Hudson Bay LP has 0.2% invested in Acceleron Pharma Inc. (NASDAQ:XLRN). Millennium Llc owns 359,304 shares. Point72 Asset Management L.P. bought a new stake in shares of Acceleron Pharma during the 3rd quarter valued at $2,721,000. Lord Abbett And stated it has 83,104 shares or 0.01% of all its holdings. Trexquant Investment LP reported 0.07% in Acceleron Pharma Inc. (NASDAQ:XLRN). 3,414 are owned by Bnp Paribas Arbitrage. American International Group Inc. now owns 21,487 shares of the biopharmaceutical company's stock worth $802,000 after buying an additional 1,607 shares in the last quarter.

Other reports by Click Lancashire

Discuss This Article